Literature DB >> 30742992

Algorithmic approach to management of acute ocular chemical injuries-I's and E's of Management.

Geetha Iyer1, Bhaskar Srinivasan2, Shweta Agarwal2.   

Abstract

Ocular chemical injuries are associated with significant morbidity leading to vision loss and ocular surface damage. Appropriate management and intervention in the acute stage dictates the final outcome as well as the prognosis for visual rehabilitative procedures in chronic stage. Classifying the parameters to be addressed in the acute stage and providing an algorithmic approach for managing the alterations in each of them will facilitate the primary goal of ensuring epithelialization of the ocular surface. Broadly categorizing them into the I's and E's (inciting agent, inflammation, epithelial defect, ischemia, exposure and intraocular pressure) and treating each will directly and/or indirectly influence re-epithelialization of the ocular surface, which in turn will reduce or prevent the various detrimental sequelae of ocular chemical injury.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allo simple limbal epithelial transplant; Chemical injury of the eye; Cornea; Limbal stem cell; Ocular chemical injury; Simple limbal epithelial transplant; Tenonplasty

Mesh:

Year:  2019        PMID: 30742992     DOI: 10.1016/j.jtos.2019.02.002

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  2 in total

1.  Toward electron-beam sterilization of a pre-assembled Boston keratoprosthesis.

Authors:  Sina Sharifi; Hannah Sharifi; Curtis Guild; Mohammad Mirazul Islam; Khoa D Tran; Corrina Patzer; Claes H Dohlman; Eleftherios I Paschalis; Miguel Gonzalez-Andrades; James Chodosh
Journal:  Ocul Surf       Date:  2021-03-03       Impact factor: 5.033

2.  Glaucoma after ocular chemical burns: Incidence, risk factors, and outcome.

Authors:  Se Hyun Choi; Mee Kum Kim; Joo Youn Oh
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.